Phase III Trial of 2-Weekly CHOP with Rituximab for Aggressive B-Cell Non-Hodgkin’s Lymphoma in Elderly Patients.
暂无分享,去创建一个
H. Holte | P. Sonneveld | M. Eriksson | P. Lugtenburg | P. Huijgens | W. Putten | P. Wijermans | D. Biesma | G. W. Imhoff | M. Kramer | M. V. M. Kooij | Monique M. C Steijaert